本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cytokinetics

49.79
+14.4640.93%
成交量:1,093.61万
成交额:5.27亿
市值:59.58亿
市盈率:-9.73
高:50.22
开:44.97
低:44.93
收:35.33
52周最高:59.39
52周最低:29.31
股本:1.20亿
流通股本:1.19亿
量比:6.44
换手率:9.18%
股息:- -
股息率:- -
每股收益(TTM):-5.1182
每股收益(LYR):-5.2646
净资产收益率:-572.15%
总资产收益率:-24.87%
市净率:-16.16
市盈率(LYR):-9.46

数据加载中...

2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities